Haleon plc: disposal of the ChapStick brand completed
31 May 2024: Haleon plc ("Haleon") has today announced that it has completed the disposal of the ChapStick brand to Suave Brands Company, a portfolio company of Yellow Wood Partners.
On 25 January 2024, Haleon announced that it had reached a binding agreement for the sale of the ChapStick brand to Suave Brands Company for pre-tax cash proceeds of approximately $430 million, as well as a passive minority interest in Suave Brands Company.
| Enquiries |
|||
| Investors |
Media |
||
| Sonya Ghobrial |
+44 7392 784784 |
Zo ë Bird |
+44 7736 746167 |
| Rakesh Patel |
+44 7552 484646 |
Gemma Thomas |
+44 7985 175048 |
| Emma White |
+44 7823 523562 |
||
| Email: corporate.media@haleon.com |
|||
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com .